Results 121 to 130 of about 5,231 (286)

Stepped‐Care Management of Insomnia: Treatment Choices Guided by a Patient Decision Aid in a Pragmatic Nonrandomized Clinical Trial Setting

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Patients with insomnia face difficult decisions when choosing between treatment options with competing risk–benefit profiles. Patient treatment choices were evaluated as part of a pragmatic nonrandomized clinical trial for a two‐step cognitive behavioural therapy for insomnia (CBT‐I) intervention. Upon enrollment, participants were guided by a
Janet M. Y. Cheung   +4 more
wiley   +1 more source

Conditional Probability of Observing a Poor Night According to Sleep Depth Among Individuals With Insomnia

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT The present study aims at verifying whether the conditional probability of observing a poor night after one, two, or three consecutive poor nights is associated with sleep depth or sleep self‐estimation. Online sleep diaries were collected for 21 consecutive nights from 30 adults with insomnia.
D. Laroche, A. Vallières, C. H. Bastien
wiley   +1 more source

One Single Session to Sleep Them All? The Potential of Single‐Session Interventions for Insomnia

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Poor sleep and insomnia are pervasive public health concerns, with insomnia ranking as the second most prevalent mental health disorder in the general population. Moreover, insomnia is a significant predictor of subsequent depression and is frequently co‐occurring with other psychological difficulties.
Matteo Carpi   +2 more
wiley   +1 more source

The Effects of Daridorexant on Patients With Comorbid Insomnia Disorder and Untreated Mild Obstructive Sleep Apnoea: A Post Hoc Subgroup Analysis of a Phase 3, Randomised Clinical Trial

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Daridorexant, a dual orexin receptor antagonist, is approved for the treatment of insomnia disorder in adults. Approximately 30%–35% of patients with insomnia disorder also have obstructive sleep apnoea (OSA) of any severity. It is unclear whether sleep medications provide safe and effective treatment for insomnia in these patients.
Christopher J. Lettieri   +8 more
wiley   +1 more source

Management of Insomnia Complaints by Non‐Sleep Specialist Physicians: A French DELPHI Consensus

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Insomnia is the most prevalent sleep disorder and a major public health concern, affecting chronically up to 19% of the adult population in France. Despite its significant impact on quality of life, mental health, and cardiometabolic disease, insomnia disorder remains underdiagnosed and inadequately managed.
Pierre‐Alexis Geoffroy   +6 more
wiley   +1 more source

Sleep Medicine—What's in a Name?

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Sleep medicine has matured into a recognised medical discipline, characterised by defined diagnostic concepts, evidence‐based treatments, and significant progress in understanding sleep physiology and disorders. Sleep and its disturbances impact virtually every aspect of health and well‐being.
Dirk A. Pevernagie   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy